Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/911
Name: Drug, bio-affecting and body treating compositions > Obesity > Bulking agent
Description: Subject matter wherein a bulking agent is used to reduce food intake.










Patents under this class:

Patent Number Title Of Patent Date Issued
8658147 Polymer hydrogels and methods of preparation thereof Feb. 25, 2014
8541392 Polymer controlled induced viscosity fiber system and uses thereof Sep. 24, 2013
7422763 Acid controlled induced viscosity fiber system and uses thereof Sep. 9, 2008
7422764 Matrix-forming composition containing pectin Sep. 9, 2008
7199160 Antiobestic agents and health foods Apr. 3, 2007
6863904 Compositions and methods for prophylactic and therapeutic supplementation of nutrition in subjects Mar. 8, 2005
6747015 Low molecular weight polymannuronate Jun. 8, 2004
6689755 Method of stabilizing biologically active substances Feb. 10, 2004
6528502 Composition and method for improved carbohydrate management in mammals Mar. 4, 2003
6312730 Psyllium-hydrocolloid gum composition Nov. 6, 2001
6024959 Pharmaceutical composition containing pectin and a phospholipid used as an antidiarrheal and antiulcer agent Feb. 15, 2000
5763409 Stable freeze-dried formulation comprising a protein assay kit Jun. 9, 1998
5700783 Method of treating urinary incontinence Dec. 23, 1997
5603950 Agent for oral intake Feb. 18, 1997
5540917 Biomass lipase inhibitor useful for treating adiposity Jul. 30, 1996
5462742 Gel-forming liquid dietary fibre composition Oct. 31, 1995
5364636 Inhibitor of absorption of digestion product of food and drink Nov. 15, 1994
5336486 Appetite control method Aug. 9, 1994
5330779 Material for food and method for production thereof Jul. 19, 1994
5324526 Algin-containing food and beverage Jun. 28, 1994
5320847 Agglomerated psyllium hydrophilic mucilloid combinates Jun. 14, 1994
5286481 Method of reducing weight in mammals Feb. 15, 1994
5268367 Composition and method for lowering blood level of LDL-cholesterol Dec. 7, 1993
5266334 Sugar-free dry mix cellulose ether compositions as bulk laxatives Nov. 30, 1993
5221668 Nutritional product for trauma and surgery patients Jun. 22, 1993
5137716 Method of reducing weight in mammals Aug. 11, 1992
5126332 Food compositions for the prevention of overeating Jun. 30, 1992
5120475 Method for preparing microcapsules having improved pre-walls, and microcapsules and photosensitive materials produced thereby Jun. 9, 1992
5114709 Ferric ion coordinated polyamine resins for the lowering of blood cholesterol May. 19, 1992
5112540 Method of making microcapsules having an improved pre-wall May. 12, 1992
5023245 Improved niacin formulation Jun. 11, 1991
4965252 Cholesterol-lowering combination compositions of guar gum and niacin Oct. 23, 1990
4963367 Drug delivery compositions and methods Oct. 16, 1990
4861871 Process for cyclo-dehydrating ketoses, obtained anhydrides and their use as food additives Aug. 29, 1989











 
 
  Recently Added Patents
Systems and methods for adaptive blind mode equalization
Vehicle, toy, and/or replicas thereof
Semiconductor device and method of manufacturing the same
Image forming system, printing control method, and program
Housing for gas flow indicator
Electronic system and method for compensating the dimensional accuracy of a 4-axis CNC machining system using global and local offsets
Providing user interfaces and window previews for hosted applications
  Randomly Featured Patents
Method and system for automated collection of call routing performance data in a wireless network
Method of repairing a spent electrode for plasma arc torch
Diffusion mask and fabrication method for forming pn-junction elements in a compound semiconductor substrate
Online game advertising system
Methods of testing multifrequency dialing signals
Clock recovery device
Kernel-level method of flagging problems in applications
Adaptor for feeding sets
Heat exchanger of plate fin type
Assay for Alzheimer's disease drug development